道琼斯指数
52,475.1
涨跌
+97.53+0.19%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 +0.19%,标普 500 指数为 +0.28%,纳斯达克综合指数为 +0.27%。个股方面,2,381 只上涨、2,738 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc.AMGN | $451.82 | +0.86% | 2.06M | $244.27B | $288.00 - $454.66 | 0.02% |
| 2 | Gilead Sciences Inc.GILD | $159.22 | +0.10% | 3.68M | $197.43B | $114.02 - $160.83 | 0.02% |
| 3 | Moderna, Inc.MRNA | $214.08 | +2.91% | 11.03M | $85.47B | $22.28 - $254.48 | 0.00% |
| 4 | IQVIA Holdings Inc.IQV | $279.01 | +2.76% | 1.41M | $45.92B | $154.50 - $284.50 | 0.00% |
| 5 | Revolution Medicines, Inc.RVMD | $188.66 | +1.31% | 717.28K | $40.44B | $56.66 - $224.31 | 0.00% |
| 6 | Biogen Inc.BIIB | $243.97 | -3.36% | 1.88M | $36.05B | $138.00 - $258.78 | 0.00% |
| 7 | Incyte Genomics Inc.INCY | $116.88 | +0.23% | 1.52M | $23.69B | $88.20 - $132.60 | 0.00% |
| 8 | Medpace Holdings, Inc.MEDP | $692.93 | +2.81% | 254.94K | $19.38B | $373.00 - $693.97 | 0.00% |
| 9 | Charles River Laboratories International, Inc.CRL | $374.05 | +4.22% | 1.10M | $17.86B | $146.19 - $378.23 | 0.00% |
| 10 | Exelixis Inc.EXEL | $66.28 | +1.47% | 1.33M | $16.42B | $36.00 - $66.38 | 0.00% |
| 11 | Neurocrine Biosciences Inc.NBIX | $145.50 | -0.32% | 866.04K | $14.79B | $122.14 - $186.12 | 0.00% |
| 12 | Halozyme Therapeutics, Inc.HALO | $130.06 | +1.20% | 1.03M | $14.76B | $61.23 - $130.24 | 0.00% |
| 13 | Bio-Techne Corp.TECH | $72.69 | +0.11% | 2.37M | $11.40B | $43.20 - $72.75 | 0.00% |
| 14 | Twist Bioscience CorporationTWST | $173.57 | +8.52% | 3.24M | $10.88B | $23.30 - $219.71 | 0.00% |
| 15 | Repligen Corp.RGEN | $184.64 | +5.06% | 1.22M | $10.42B | $100.99 - $198.87 | 0.00% |
| 16 | Kymera Therapeutics, Inc.KYMR | $122.67 | +4.26% | 627.89K | $10.20B | $55.66 - $130.05 | 0.00% |
| 17 | Krystal Biotech, Inc.KRYS | $321.24 | +0.23% | 163.78K | $9.51B | $183.26 - $382.54 | 0.00% |
| 18 | ImmunityBio, Inc.IBRX | $8.82 | +2.32% | 6.35M | $9.35B | $1.95 - $12.43 | 0.00% |
| 19 | Vaxcyte, Inc.PCVX | $61.45 | +1.28% | 1.81M | $9.14B | $39.87 - $90.75 | 0.00% |
| 20 | Iovance Biotherapeutics, Inc.IOVA | $14.82 | +1.71% | 7.77M | $6.71B | $1.76 - $15.37 | 0.00% |
| 21 | Kodiak Sciences Inc.KOD | $97.05 | +6.19% | 854.78K | $6.10B | $15.83 - $104.00 | 0.00% |
| 22 | Immunovant, Inc.IMVT | $29.44 | +2.01% | 1.02M | $6.08B | $21.34 - $45.42 | 0.00% |
| 23 | CG Oncology, Inc.CGON | $64.02 | +1.68% | 433.96K | $5.67B | $35.80 - $80.97 | 0.00% |
| 24 | Scholar Rock Holding CorporationSRRK | $43.25 | +1.80% | 1.29M | $5.27B | $27.07 - $61.76 | 0.00% |
| 25 | CRISPR Therapeutics AGCRSP | $54.09 | +5.07% | 919.42K | $5.23B | $44.12 - $65.98 | 0.00% |
| 26 | Adaptive Biotechnologies CorporationADPT | $28.35 | +2.49% | 1.92M | $4.53B | $12.00 - $30.74 | 0.00% |
| 27 | Relay Therapeutics, Inc.RLAY | $19.67 | +4.46% | 2.35M | $4.31B | $5.95 - $21.27 | 0.00% |
| 28 | Tarsus Pharmaceuticals, Inc.TARS | $72.12 | +1.94% | 312.98K | $3.56B | $53.89 - $91.53 | 0.00% |
| 29 | Denali Therapeutics Inc.DNLI | $19.28 | +0.36% | 1.28M | $3.08B | $13.75 - $27.30 | 0.00% |
| 30 | Beam Therapeutics Inc.BEAM | $28.79 | +15.70% | 4.43M | $2.97B | $20.23 - $38.26 | 0.00% |
| 31 | ADMA Biologics, Inc.ADMA | $11.29 | +1.07% | 2.14M | $2.53B | $7.21 - $20.46 | 0.00% |
| 32 | Recursion Pharmaceuticals, Inc.RXRX | $4.34 | +7.28% | 26.93M | $2.33B | $2.77 - $6.10 | 0.00% |
| 33 | BioCryst Pharmaceuticals Inc.BCRX | $8.38 | +3.46% | 3.43M | $2.14B | $6.23 - $11.22 | 0.00% |
| 34 | Vericel CorporationVCEL | $40.99 | -5.21% | 583.89K | $2.10B | $28.95 - $49.32 | 0.00% |
| 35 | Absci CorporationABSI | $11.88 | +12.49% | 5.44M | $2.04B | $2.24 - $12.05 | 0.00% |
| 36 | Vir Biotechnology, Inc.VIR | $11.93 | +3.20% | 1.27M | $2.02B | $4.82 - $12.00 | 0.00% |
| 37 | Maze Therapeutics, Inc.MAZE | $31.70 | +0.03% | 331.99K | $1.73B | $21.95 - $53.65 | 0.00% |
| 38 | Novavax Inc.NVAX | $10.31 | +2.89% | 4.06M | $1.70B | $6.20 - $13.38 | 0.00% |
| 39 | Hemab Therapeutics Holdings, Inc.COAG | $38.55 | +0.29% | 346.93K | $1.68B | $23.00 - $55.42 | 0.00% |
| 40 | Replimune Group, Inc.REPL | $16.02 | +22.91% | 6.81M | $1.50B | $1.50 - $16.75 | 0.00% |
| 41 | Taysha Gene Therapies, Inc.TSHA | $4.24 | -0.47% | 2.86M | $1.38B | $3.46 - $7.30 | 0.00% |
| 42 | Vor Biopharma Inc.VOR | $20.69 | +5.60% | 896.11K | $1.22B | $6.50 - $26.80 | 0.00% |
| 43 | Inhibrx Biosciences, Inc.INBX | $73.50 | -23.38% | 1.15M | $1.08B | $57.30 - $155.29 | 0.00% |
| 44 | Cullinan Therapeutics, Inc.CGEM | $15.57 | +4.92% | 444.35K | $1.00B | $6.73 - $23.19 | 0.00% |
| 45 | Prime Medicine, Inc.PRME | $5.36 | +23.33% | 14.64M | $972.36M | $2.67 - $5.43 | 0.00% |
| 46 | MeiraGTx Holdings plcMGTX | $9.75 | +3.67% | 492.41K | $936.04M | $6.62 - $15.35 | 0.00% |
| 47 | Odyssey Therapeutics, Inc.ODTX | $19.47 | +0.05% | 187.79K | $927.53M | $15.10 - $29.05 | 0.00% |
| 48 | Monte Rosa Therapeutics, Inc.GLUE | $10.84 | +1.59% | 1.34M | $924.63M | $9.68 - $25.77 | 0.00% |
| 49 | Sana Biotechnology, Inc.SANA | $2.64 | +6.88% | 2.84M | $789.11M | $2.22 - $5.58 | 0.00% |
| 50 | OmniAb, Inc.OABI | $5.28 | +6.65% | 1.45M | $765.02M | $1.30 - $5.43 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。